CoreAge Rx vs Coivas
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Coivas head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Coivas a bad call — it's best for readers comparing ongoing compounded care who will check the full price and unusually detailed guarantee conditions. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Coivas |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the selected plan Semaglutide advertised from $119/month; complete supply and commitment require a quote. The conditional refund guarantee requires six continuous paid months and verified eligibility; it is not a routine cancellation refund. Full price detailsCompounded semaglutide offered; complete selected-plan quote unknown; advertised from $119/month without a full selected supply and commitment |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the selected plan Tirzepatide advertised from $199/month; complete supply and commitment require a quote. The conditional refund guarantee requires six continuous paid months and verified eligibility; it is not a routine cancellation refund. Full price detailsCompounded tirzepatide offered; complete selected-plan quote unknown; advertised from $199/month without a full selected supply and commitment |
| Coverage | US only; restrictions by state, confirmed at intake | FAQ advertises all fifty states; individual medication eligibility remains subject to the independent clinician and pharmacy |
| Brand-name access | Not confirmed | Branded drugs appear as guarantee exclusions, not proof of an available branded prescription offer. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Coivas: From $119/$199 monthly requires a selected-plan quote. The guarantee needs six continuous paid months and verified no weight reduction; it is not a routine cancellation refund.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.